Hanagiri Takeshi, Ono Kenji, Baba Teturo, So Tetsuya, Yamasaki Masaharu, Nagata Yoshika, Uramoto Hidetaka, Takenoyama Mitsuhiro, Yasumoto Kosei
Second Department of Surgery, University of Occupational and Environmental Health, Kitakyushu, Japan.
Int Surg. 2010 Apr-Jun;95(2):126-9.
The mucinous carcinoma of breast cancer is a relatively rare malignant tumor. This study investigated the clinical and pathologic features of mucinous carcinoma. The medical records of 237 patients with invasive breast cancer who underwent surgery between 1995 and 2006 were reviewed. These cases included 10 patients (4.2%) with mucinous carcinoma. The age of the patients ranged from 43 to 71 years (mean, 55.5 years). The tumor size was T1 in 5 patients and T2 in 5 patients. Lymph node metastasis was diagnosed as being negative in 9 patients and positive in 1 patient. Six patients (60%) were positive both for estrogen and progesterone receptor. The 10-year survival rates of mucinous carcinoma and other types of invasive breast cancer were 87.5% and 80.7%, respectively. Mucinous carcinoma showed a lower incidence of lymph node metastasis than other types of invasive breast cancer. Mucinous carcinoma tended to have a better prognosis in comparison with other types of invasive breast carcinoma.
乳腺黏液癌是一种相对罕见的恶性肿瘤。本研究调查了黏液癌的临床和病理特征。回顾了1995年至2006年间接受手术的237例浸润性乳腺癌患者的病历。这些病例包括10例(4.2%)黏液癌患者。患者年龄在43岁至71岁之间(平均55.5岁)。肿瘤大小为T1的患者有5例,T2的患者有5例。9例患者诊断为淋巴结转移阴性,1例患者为阳性。6例患者(60%)雌激素和孕激素受体均为阳性。黏液癌和其他类型浸润性乳腺癌的10年生存率分别为87.5%和80.7%。黏液癌的淋巴结转移发生率低于其他类型的浸润性乳腺癌。与其他类型的浸润性乳腺癌相比,黏液癌往往预后更好。